Atherosclerosis is one of the primary causes of cardiovascular disease; the number one cause of death in the western society. Atherosclerotic plaque formation is a dynamic multi-cellular process... Show moreAtherosclerosis is one of the primary causes of cardiovascular disease; the number one cause of death in the western society. Atherosclerotic plaque formation is a dynamic multi-cellular process where regulation of different genes essentially determines the activity of the different cell types involved. Gene expression is regulated, amongst others, by epigenetic processes. Epigenetic mechanisms change the accessibility of the DNA sequence and is thought to form a link between environmental factors and gene expression. Epigenetics may therefor play an important role in atherosclerosis pathology. The research described in this thesis evaluated the role of epigenetic regulation on various aspects of atherosclerosis pathology. It was found that the epigenetic H3K27Me3-mark was reduced in later stages of the disease. Monocytes differentiating into dendritic cells and macrophages (an important process in atherosclerosis pathology) showed higher transcription of the epigenetic regulatory gene KMT1c. Specifically blocking this gene resulted in reduction of DC-SIGN (a dendritic cell specific molecule) expression. By specifically blocking other epigenetic proteins, CCR5 (a molecule important to monocyte migration) was re-expressed on cells which did not express CCR5. This shows that epigenetic regulation is an important process in atherosclerosis pathology and might prove to be novel pharmacological target for treatment of atherosclerosis. Show less
Colorectal cancer is one of the most common diagnosed cancers worldwide, and is the second most important cause of cancer mortality in Europe. The current TNM staging system used at the time of... Show moreColorectal cancer is one of the most common diagnosed cancers worldwide, and is the second most important cause of cancer mortality in Europe. The current TNM staging system used at the time of diagnosis is insufficient, as patients with the same tumor stage show wide variations in survival and tumor recurrence. Therefore, there is a need for identification of new biomarkers in colorectal cancer in order to identify high-risk patients and to guide treatment decision-making. In this thesis, epigenetic markers, including DNA methylation and histone modifications were studied in colorectal cancer patients. Several epigenetic clinically prognostic biomarkers were identified in colorectal cancer in this thesis, including both genome-wide and gene-specific patterns of DNA methylation and histone modifications. Knowledge of tumor biology is of key importance in the development of new therapies and the making of informed treatment decisions. Pathway-focused approaches, as presented in this thesis, provide information regarding possible synergistic interactions of biomarkers. Epigenetic mechanisms are unquestionably tied to the tumorigenic process and should be considered as a grand new source of information not only for identification of prognostic and predictive biomarkers, but also for the development of new, possibly tumor- and therefore patient-specific, anti-cancer therapies. Show less